Table 2.
Self-reported illicit opioid use in prior 28 days results pre- and post-PTOEND intervention, with regression estimates and 95 % confidence intervals.
| Baseline use days, m(SD) | Endpoint use days, m(SD) | Intercept | Time (95 % confidence interval), p-value | PRSS* group (95% confidence interval) | |
|---|---|---|---|---|---|
| Month 3 Endpoint (N = 65a) | |||||
| 26.6 (4.5) | 19.3 (11.7) | 25.48 | −7.17 (−9.71, −4.64), p < 0.0001 | 2.12 (-0.89, 5.13) | |
| Month 6 Endpoint (N = 58) | |||||
| 26.4 (4.7) | 19.2 (10.7) | 26.43 | −7.36 (−9.97, −4.76), p < 0.0001 | 0.21 (-2.47, 2.90) | |
| Month 12 Endpoint (N = 44) | |||||
| 26.1 (5.4) | 16.8 (12.9) | 26.04 | −9.77 (−12.83, −6.71), p < 0.0001 | 0.99 (-2.16, 4.14) | |
a
1 of the 66 participants attending the Month 3 visit did not provide self-report substance use data.
*
randomization to Peer Recovery Support Service group was considered a nuisance covariate; the estimate of interest is “time”.